Heald Expands Access to AI-Powered Glucose Intelligence for Over-the-Counter CGM Users

Product / Tech
โดย GlobeNewswire·Read original
Summary · why it matters

Heald announced that consumers purchasing a Dexcom Stelo or Abbott Lingo continuous glucose monitor through Heald will now receive complimentary access to its AI-powered Glucose Intelligence platform. The platform interprets glucose trends and provides AI-driven recommendations, including meal analysis, barcode scanning, wearable integration, restaurant recommendations, weekly meal and fitness plans, and community support, all within a single application. Personalized meal plans tailored to each user's glucose patterns have also been introduced. The offering is available immediately through Heald's Buy Your CGM page, with sensors typically shipping within two to three business days. Heald also offers an optional membership program that pairs Glucose Intelligence with nutritionists, fitness coaches, and behavioral coaches for those seeking additional clinical guidance.

Impact on stocks 2

Biotech & Genomic Medicine · 2 stocks
Abbott Laboratories
ABT
▲ PositiveDemandrelevance

Heald's offering includes Abbott's Lingo CGM, potentially increasing demand for Abbott's product.

DexCom Inc
DXCM
▲ PositiveDemandrelevance

Heald's offering includes Dexcom's Stelo CGM, potentially increasing demand for Dexcom's product.

Off-coverage companies 1

HealdPrivate▲ Positive
Technologyrelevance

Heald expands access to its AI-powered Glucose Intelligence platform, enhancing its product offering.